U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.
Statement outlines specific solutions to patient-manipulation by “PBMs”.
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
Event opens NACDS’ 90th anniversary celebration; brings together pharmacy chains with between four and 250 locations and their supplier partners.
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
NACDS: Floridians, all Americans deserve better than the current “pharmaceutical benefit manipulation”
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
It is a two-year anniversary that patients and pharmacies can appreciate. With a unanimous decision on December 10, 2020, the U.S. Supreme Court upheld an Arkansas law that confronts the damaging tactics of prescription-drug middlemen known as pharmacy benefit managers (PBMs). NACDS had submitted an amicus brief in this case, Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association (PCMA).
Continues momentum in Tennessee and nationwide to advance patients’ health, convenience, and savings by confronting PBM tactics.
